GRAL vs GTBP (GRAIL Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 29 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
US Market Trading Session Active
Active trading session is live as of 3:17 PM ET. Prices update dynamically and reflect the latest trade records across major US exchanges. Official closing prices settle after 4:00 PM ET.
GRAL leads by +1.87% Alpha Spread Today
GRAL is trading at +2.97% while GTBP is at +1.10% .
Started At
Official opening auction price
Last Recorded Trade Price
Last recorded trade as of 3:17 PM ET
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | GRAL | GTBP | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | +2.97% | +1.10% | GRAL +1.87% |
| Net Dollar Move | +$3.94 | +$0.08 | GRAL higher move |
| Open Price | $133.49 | $7.08 | Gap: 0.65% vs 4.12% |
| Day High | $140.88 | $7.10 | Session peaks |
| Day Low | $131.20 | $6.71 | Session troughs |
| Intraday Spread | $9.68 | $0.39 | High/Low spread |
| Share Volume | 904.0K | 34.4K | GRAL more active |
| Est. Dollar Volume | $123.45M | $236.7K | GRAL higher liquidity |
Explore GRAL vs GTBP Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.